Molecular Analysis of SALL1 Mutations in Townes-Brocks Syndrome

Autor: Kohlhase, Jürgen, Taschner, Peter E.M., Burfeind, Peter, Pasche, Bastian, Newman, Bill, Blanck, Christopher, Breuning, Martijn H., ten Kate, Leo P., Maaswinkel-Mooy, Petra, Mitulla, Beate, Seidel, Jörg, Kirkpatrick, Susan J., Pauli, Richard M., Wargowski, David S., Devriendt, Koen, Proesmans, Willem, Gabrielli, Orazio, Coppa, Giovanni V., Wesby–van Swaay, Eveline, Trembath, Richard C., Schinzel, Albert A., Reardon, William, Seemanova, Eva, Engel, Wolfgang

Publikováno v: In The American Journal of Human Genetics 1999 64(2):435-445

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Autor: Hisashi Yamanaka, Askling, Johan, Berglind, Niklas, Franzen, Stefan, Frisell, Thomas, Garwood, Christopher, Greenberg, Jeffrey D., Ho, Meilien, Holmqvist, Marie, Horne, Laura Novelli, Eisuke Inoue, Michaud, Kaleb, Pappas, Dimitrios A., Reed, George, Symmons, Deborah, Eiichi Tanaka, Tran, Trung N., Verstappen, Suzanne M. M., Wesby-van Swaay, Eveline, Nyberg, Fredrik

Publikováno v: RMD Open; 10/10/2017, Vol. 3 Issue 2, p1-11, 11p

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

Autor: Yamanaka H; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan., Askling J; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden., Berglind N; Biometric & Information Sciences, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden., Franzen S; Biometric & Information Sciences, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden., Frisell T; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Garwood C; Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK., Greenberg JD; NYU School of Medicine, New York City, New York, USA.; Corrona LLC, Southborough, Massachusetts, USA., Ho M; Clinical, Global Medicines Development, AstraZeneca R&D, Alderley Park, Macclesfield, UK., Holmqvist M; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden., Novelli Horne L; Medical Evidence & Observational Research Centre, Global Medical Affairs, AstraZeneca, Wilmington, Delaware, USA., Inoue E; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan., Michaud K; University of Nebraska Medical Center, Omaha, Nebraska, USA.; National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA., Pappas DA; Corrona LLC, Southborough, Massachusetts, USA.; The College of Physicians and Surgeons, Columbia University, New York City, New York, USA., Reed G; Corrona LLC, Southborough, Massachusetts, USA.; University of Massachusetts Medical School, Worcester, Massachusetts, USA., Symmons D; Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK.; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Tanaka E; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan., Tran TN; MedImmune, Gaithersburg, Maryland, USA., Verstappen SMM; Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK., Wesby-van Swaay E; Patient Safety, GRAPSQA, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden., Nyberg F; Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Medical Evidence & Observational Research Centre, Global Medical Affairs, AstraZeneca R&D, Mölndal, Sweden.

Publikováno v: RMD open [RMD Open] 2017 Oct 10; Vol. 3 (2), pp. e000498. Date of Electronic Publication: 2017 Oct 10 (Print Publication: 2017).